206,550 Baxter International Inc. $BAX Shares Sold by RWC Asset Management LLP

RWC Asset Management LLP lowered its holdings in Baxter International Inc. (NYSE:BAX) by 6.2% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,122,618 shares of the medical instruments supplier’s stock after selling 206,550 shares during the quarter. Baxter International accounts for about 2.8% of RWC Asset Management LLP’s holdings, making the stock its 6th biggest position. RWC Asset Management LLP’s holdings in Baxter International were worth $74,943,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of BAX. CX Institutional raised its holdings in Baxter International by 2.3% during the third quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock worth $477,000 after buying an additional 448 shares during the last quarter. Baird Financial Group Inc. lifted its stake in shares of Baxter International by 1.1% in the second quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock valued at $953,000 after buying an additional 476 shares in the last quarter. CWA Asset Management Group LLC lifted its stake in shares of Baxter International by 5.0% in the third quarter. CWA Asset Management Group LLC now owns 12,617 shares of the medical instruments supplier’s stock valued at $303,000 after buying an additional 599 shares in the last quarter. Empirical Finance LLC grew its holdings in shares of Baxter International by 3.5% during the second quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock valued at $387,000 after buying an additional 608 shares during the last quarter. Finally, CYBER HORNET ETFs LLC grew its holdings in shares of Baxter International by 52.4% during the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 740 shares during the last quarter. Institutional investors own 90.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Wolfe Research assumed coverage on shares of Baxter International in a research report on Tuesday. They set a “peer perform” rating for the company. Weiss Ratings lowered shares of Baxter International from a “sell (d)” rating to a “sell (d-)” rating in a report on Thursday, October 8th. Citigroup dropped their price target on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Wells Fargo & Company lifted their price target on Baxter International from $19.00 to $23.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, UBS Group boosted their price objective on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Baxter International has an average rating of “Reduce” and an average price target of $21.73.

Baxter International Stock Down 1.3%

Shares of BAX traded down $0.33 during trading hours on Friday, reaching $25.32. 4,936,022 shares of the stock traded hands, compared to its average volume of 6,154,588. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The stock has a fifty day simple moving average of $24.76 and a 200 day simple moving average of $22.15. Baxter International Inc. has a 52 week low of $15.73 and a 52 week high of $30.00. The company has a market cap of $13.09 billion, a price-to-earnings ratio of -12.23, a PEG ratio of 3.88 and a beta of 0.65.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.80 billion. During the same period in the previous year, the company earned $0.59 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities analysts forecast that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Friday, August 28th were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s dividend payout ratio (DPR) is currently -1.93%.

Baxter International Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.